A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Recruiting · NCT06944587 · Registry updated 2025-04-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer | Borderline Resectable Pancreatic Cancer; Chemotherapy Effect; Locally Advanced Pancreatic Cancer; Pancreatectomy | Recruiting | Not stated | 2025-04-25 | NCT06944587 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haukeland University Hospital | 163 |
| Helse Stavanger HF | 67 |
| Oslo University Hospital | 327 |
| St. Olavs Hospital | 167 |
| University Hospital of North Norway | 93 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Haukeland University Hospital | Bergen | Norway | 2 |
| Oslo University Hospital | Oslo | Norway | 37 |
| St. Olavs Hospital, Trondheim University Hospital | Trondheim | Norway | 1 |
| Stavanger University Hospital | Stavanger | Norway | 1 |
| University Hospital of North Norway | Tromsø | Norway | 1 |